Annual Total Long Term Liabilities
$1.61 M
+$1.56 M+2729.82%
December 31, 2023
Summary
- As of March 13, 2025, COCP annual total long term liabilities is $1.61 million, with the most recent change of +$1.56 million (+2729.82%) on December 31, 2023.
- During the last 3 years, COCP annual total long term liabilities has risen by +$1.23 million (+325.59%).
- COCP annual total long term liabilities is now -99.34% below its all-time high of $243.47 million, reached on December 31, 2014.
Performance
COCP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.58 M
+$53.00 K+3.47%
September 30, 2024
Summary
- As of March 13, 2025, COCP quarterly total long term liabilities is $1.58 million, with the most recent change of +$53.00 thousand (+3.47%) on September 30, 2024.
- Over the past year, COCP quarterly long term liabilities has increased by +$1.58 million (+100.00%).
- COCP quarterly long term liabilities is now -99.35% below its all-time high of $243.47 million, reached on December 31, 2014.
Performance
COCP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
COCP Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2729.8% | +100.0% |
| 3 y3 years | +325.6% | +2675.4% |
| 5 y5 years | +1278.6% | +2675.4% |
COCP Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2729.8% | -1.9% | -100.0% |
| 5 y | 5-year | at high | +2729.8% | -1.9% | -100.0% |
| alltime | all time | -99.3% | -100.0% | -99.3% | -100.0% |
Cocrystal Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.58 M(+3.5%) |
| Jun 2024 | - | $1.53 M(-3.4%) |
| Mar 2024 | - | $1.58 M(-1.9%) |
| Dec 2023 | $1.61 M(+2729.8%) | $1.61 M(>+9900.0%) |
| Sep 2023 | - | $0.00(-100.0%) |
| Jun 2023 | - | $10.00 K(-63.0%) |
| Mar 2023 | - | $27.00 K(-52.6%) |
| Dec 2022 | $57.00 K(-80.9%) | $57.00 K(-52.1%) |
| Sep 2022 | - | $119.00 K(-32.8%) |
| Jun 2022 | - | $177.00 K(-24.4%) |
| Mar 2022 | - | $234.00 K(-21.5%) |
| Dec 2021 | $298.00 K(-21.4%) | $298.00 K(-16.8%) |
| Sep 2021 | - | $358.00 K(+23.4%) |
| Jun 2021 | - | $290.00 K(-13.7%) |
| Mar 2021 | - | $336.00 K(-11.3%) |
| Dec 2020 | $379.00 K(-29.4%) | $379.00 K(-10.8%) |
| Sep 2020 | - | $425.00 K(-11.5%) |
| Jun 2020 | - | $480.00 K(-1.0%) |
| Mar 2020 | - | $485.00 K(-9.7%) |
| Dec 2019 | $537.00 K(+359.0%) | $537.00 K(-8.5%) |
| Sep 2019 | - | $587.00 K(-7.6%) |
| Jun 2019 | - | $635.00 K(-11.6%) |
| Mar 2019 | - | $718.00 K(+513.7%) |
| Dec 2018 | $117.00 K(-99.2%) | $117.00 K(-99.0%) |
| Sep 2018 | - | $12.13 M(-3.9%) |
| Jun 2018 | - | $12.63 M(-17.1%) |
| Mar 2018 | - | $15.23 M(+4.4%) |
| Dec 2017 | $14.59 M(-28.9%) | $14.59 M(-28.8%) |
| Sep 2017 | - | $20.50 M(-0.0%) |
| Jun 2017 | - | $20.50 M(-0.0%) |
| Mar 2017 | - | $20.51 M(-0.1%) |
| Dec 2016 | $20.52 M | $20.52 M(-58.9%) |
| Sep 2016 | - | $49.93 M(-0.0%) |
| Jun 2016 | - | $49.93 M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $49.93 M(-0.0%) |
| Dec 2015 | $49.94 M(-79.5%) | $49.94 M(-23.5%) |
| Sep 2015 | - | $65.26 M(-0.0%) |
| Jun 2015 | - | $65.26 M(0.0%) |
| Mar 2015 | - | $65.26 M(-73.2%) |
| Dec 2014 | $243.47 M(+2308.7%) | $243.47 M(>+9900.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $10.11 M(>+9900.0%) | $10.11 M(+265.7%) |
| Sep 2013 | - | $2.76 M(-4.7%) |
| Jun 2013 | - | $2.90 M(-1.9%) |
| Mar 2013 | - | $2.96 M(>+9900.0%) |
| Dec 2012 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2012 | - | $2.91 M(-1.4%) |
| Jun 2012 | - | $2.95 M(-1.4%) |
| Mar 2012 | - | $3.00 M(-1.4%) |
| Dec 2011 | $3.04 M(-0.2%) | $3.04 M(-1.6%) |
| Sep 2011 | - | $3.09 M(-3.9%) |
| Jun 2011 | - | $3.21 M(>+9900.0%) |
| Mar 2011 | - | $0.00(-100.0%) |
| Dec 2010 | $3.04 M(>+9900.0%) | $3.04 M(>+9900.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00 | $0.00 |
FAQ
- What is Cocrystal Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cocrystal Pharma?
- What is Cocrystal Pharma annual total long term liabilities year-on-year change?
- What is Cocrystal Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly long term liabilities year-on-year change?
What is Cocrystal Pharma annual total long term liabilities?
The current annual total long term liabilities of COCP is $1.61 M
What is the all time high annual total long term liabilities for Cocrystal Pharma?
Cocrystal Pharma all-time high annual total long term liabilities is $243.47 M
What is Cocrystal Pharma annual total long term liabilities year-on-year change?
Over the past year, COCP annual total long term liabilities has changed by +$1.56 M (+2729.82%)
What is Cocrystal Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of COCP is $1.58 M
What is the all time high quarterly long term liabilities for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly total long term liabilities is $243.47 M
What is Cocrystal Pharma quarterly long term liabilities year-on-year change?
Over the past year, COCP quarterly total long term liabilities has changed by +$1.58 M (+100.00%)